You are here

Media Coverage

November 17, 2014
NPR All Things Considered
After years of setbacks, Alzheimer's researchers are sounding optimistic again. The reason: a brain protein called tau.
November 12, 2014
NBC News
Men's semen appears to give the AIDS virus an extra boost, researchers from the Gladstone Institutes reported Wednesday in a finding they say may explain why it’s so hard to develop creams or gels to prevent infection.
Semen boosts the infectiousness of the AIDS virus and renders ineffective many promising gels aimed at blocking HIV, according to UCSF/Gladstone Institutes researchers. However, they believe new drugs could undercut semen's HIV-enhancing effect and provide a new way to obstruct the virus.
October 28, 2014
Huffington Post

Dr. Robert Grant writes for the Huffington Post about use PrEP to finally end HIV transmission in San Francisco

October 15, 2014
ABC 7 News

Dr. Leor Weinberger discusses possible treatments for Ebola with ABC 7 News and stresses the need for research into new anti-virals that can treat a broad range of infections.

October 4, 2014
Market Watch

Gladstone investigator Dr. Steven Finkbeiner is part of a consortium receiving funding from the ALS Association Ice Bucket Challenge donations, investigating new potential treatments for ALS.

September 20, 2014
The Dallas Morning News

Dr. Deepak Srivastava, Director of the Gladstone Institute of Cardiovascular Disease, discusses the future of cardiac reprogramming, the potentially life-saving technique that he pioneered.

September 19, 2014
The Guardian

Gladstone senior investigator Dr. Robert Grant recommends PrEP for HIV prevention be used like contraception.

September 19, 2014

The Gladstone Institutes Dr. Robert Grant, who led the research on Truvada, confirms that the drug is safe and highly effective.

September 18, 2014
San Francisco Chronicle

Dr. Warner Greene discusses the need for better health care systems in Africa with the current Ebola outbreak.